This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Applied Medical Enzyme Research Institute Corporation. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovations by Makoto Irahara in Allergy Prediction
Introduction
Makoto Irahara is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of allergy prediction through his innovative methods. His work focuses on understanding and predicting the risk of developing allergies in infants.
Latest Patents
Irahara holds a patent for a method that collects data to predict the risk of developing allergies. This patent, titled "Method for collecting data to predict risk of developing allergies," provides a means for predicting an infant's risk of developing an allergy to an allergen. The method involves measuring IgG1 and IgE antibody titers against egg white in infants aged six months or younger using a DCP chip. A scattergram is created by plotting the IgG1 antibody titer on the X-axis and the IgE antibody titer on the Y-axis. The data distribution is divided into two blocks, and a linear function applicable to each block is calculated. This allows for the prediction of an infant's risk of developing an allergy based on which block they belong to. Irahara has 1 patent to his name.
Career Highlights
Makoto Irahara is associated with the Applied Medical Enzyme Research Institute Corporation. His work at this institution has allowed him to focus on innovative research in the medical field, particularly in allergy prediction.
Collaborations
Irahara has collaborated with notable colleagues such as Hiroshi Kido and Koichi Suzuki. Their combined expertise has contributed to advancements in the field of allergy research.
Conclusion
Makoto Irahara's innovative approach to predicting allergies in infants showcases the importance of research in medical science. His contributions have the potential to improve the understanding and management of allergies, benefiting many families.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile